Skip to main content
SpringerLink
Log in

Extended-spectrum β-lactamase-producing Shigella strains in Israel, 2000–2004

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Routine susceptibility testing of 5,616 Shigella isolates at the National Shigella Reference Centre in Israel over a 5-year period (2000–2004) revealed resistance to ceftriaxone in one strain of Shigella boydii 2 and in two strains each of Shigella flexneri 2a, S. flexneri 6, and Shigella sonnei. All seven isolates were confirmed as producers of extended-spectrum β-lactamase (ESBL) by the combination disk method, the Vitek 1 system, and a modification of the double-disk synergy test, which is based on the inhibitory properties of clavulanic acid, tazobactam, and sulbactam. Tazobactam had the strongest effect in all seven strains. Molecular characterization of the ESBLs identified CTX-M-type enzymes, consisting of the CTX-M-9 group (n = 3), CTX-M-3 (n = 2), CTX-M-39 (n = 1), and CTX-M-2 group (n = 1). Three of the strains also carried bla-OXA genes and a bla-TEM gene. Although the prevalence of ESBLs in this study was low, further research is needed on the spread and transfer of resistance genes, both in hospitals and in the community.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Ahamed J, Kundu M (1999) Molecular characterization of the SHV-11 β-lactamase of Shigella dysenteriae. Antimicrob Agents Chemother 43:2081–2083

    PubMed  CAS  Google Scholar 

  2. Jeong YS, Lee JC, Kang HY, Yu HS, Lee EY, Choi CH, Tae SH, Lee YC, Cho DT, Seol SY (2003) Epidemiology of nalidixic acid resistance and TEM-1- and TEM-52-mediated ampicillin resistance of Shigella sonnei isolates obtained in Korea between 1980 and 2000. Antimicrob Agents Chemother 47:3719–3723

    Article  PubMed  CAS  Google Scholar 

  3. Schumacher H, Nir M, Mansa B, Grassy A (1992) β-Lactamases in Shigella. APMIS 100:954–956

    Article  PubMed  CAS  Google Scholar 

  4. Livermore DM (1995) β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8:557–584

    PubMed  CAS  Google Scholar 

  5. Walter-Rasmussen J, Høiby N (2004) Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum β-lactamases. Can J Microbiol 50:137–165

    Article  Google Scholar 

  6. Bonnet R (2004) Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48:1–14

    Article  PubMed  CAS  Google Scholar 

  7. Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, Johnson AP, Pike R, Warner M, Cheasty T, Pearson A, Harry S, Leach JB, Loughrey A, Lowes JA, Warren RE, Livermore D (2004) Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother 54:735–743

    Article  PubMed  CAS  Google Scholar 

  8. Pitout JDD, Hanson ND, Church DL, Laupland KB (2004) Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum β-lactamases: importance of community isolates with bla CTX-M genes. Clin Infect Dis 38:1736–1741

    Article  PubMed  CAS  Google Scholar 

  9. Pallecci L, Malossi M, Mantella A, Gotuzzo E, Trigoso C, Bartoloni A, Paradisi F, Kronvall G, Rossolini GM (2004) Detection of CTX-M-type β-lactamase gene in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. Antimicrob Agents Chemother 48:4556–4561

    Article  CAS  Google Scholar 

  10. Bou G, Cartelle M, Tomas M, Canle D, Molina F, Moure R, Eiros JM, Guerrero A (2002) Identification and broad dissemination of CTX-M-14 β-lactamase in different Escherichia coli strains in the northwest area of Spain. J Clin Microbiol 40:4030–4036

    Article  PubMed  CAS  Google Scholar 

  11. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y (2006) Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42:925–934

    Article  PubMed  CAS  Google Scholar 

  12. Borer A, Gilad J, Menashe G, Peled N, Reisenberg K, Schlaeffer F (2002) Extended-spectrum beta-lactamase producing Enterobacteriaceae strains in southern Israel. Med Sci Monit 8:CR44-CR47

    PubMed  Google Scholar 

  13. Navon-Venezia S, Hammer-Munz O, Schwartz D, Turner D, Kuzmenko B, Carmeli Y (2003) Occurrence and phenotypic characteristics of extended-spectrum β-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests. J Clin Microbiol 41:155–158

    Article  PubMed  CAS  Google Scholar 

  14. Colodner R, Raz R, Chazan B, Sakran W (2004) Susceptibility pattern of extended spectrum β-lactamase producing bacteria isolated from inpatients to five antimicrobial drugs in a community hospital in Northern Israel. Int J Antimicrob Agents 24:409–410

    Article  PubMed  CAS  Google Scholar 

  15. Mendelson G, Hait V, Ben-Israel J, Gronich D, Granot E, Raz R (2005) Prevalence and risk factors of extended-spectrum-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Microbiol Infect Dis 24:17–22

    Article  CAS  Google Scholar 

  16. Vasilev V, Japheth R, Yishai R, Andorn N (2004) Antimicrobial resistance of Shigella flexneri serotypes in Israel during a period of three years: 2000–2002. Epidemiol Infect 132:1049–1054

    Article  PubMed  CAS  Google Scholar 

  17. Bauer AW, Kirby WM, Sherris JC, Turk N (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 36:493–496

    Google Scholar 

  18. National Committee for Clinical Laboratory Standards (1999) Performance standards for antimicrobial susceptibility testing. Approved standard M100–S9. NCCLS, Wayne, PA

    Google Scholar 

  19. National Committee for Clinical Laboratory Standards (2003) Performance standards for antimicrobial susceptibility testing. 13th informational supplement. Document M100–S13 (M2), for use with M2-A8-Disk Diffusion. NCCLS, Wayne, PA

    Google Scholar 

  20. National Committee for Clinical Laboratory Standards (2003) Performance standards for antimicrobial disk susceptibility tests. Approved standard M2–A8. NCCLS, Wayne, PA

    Google Scholar 

  21. European Antimicrobial Resistance Surveillance System (2004) Protocol for ESBL reporting. EARSS manual. National Institute of Public Health and Environmental Hygiene (RIVM), Bilthoven, the Netherlands, pp 26–27

    Google Scholar 

  22. Thomson K, Molland E (2004) Newer β-lactamases: clinical and laboratory implications (in-house manual). Center for Research in Antiinfectives and Biotechnology. Department of Medical Microbiology and Immunology, Creighton University School of Medicine. Omaha, Nebraska, pp 5–6

  23. Bush K, Macalintal C, Rasmussen BA, Lee VJ, Yang Y (1993) Kinetic interactions of tazobactam with β-lactamases from all major structural classes. Antimicrob Agents Chemother 37:851–858

    PubMed  CAS  Google Scholar 

  24. Tzouvelekis LS, Tzelepi E, Tassios PT, Legakis NJ (2000) CTX-M- type β-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents 14:137–142

    Article  PubMed  CAS  Google Scholar 

  25. Poirel P, Gniadkowski M, Nordman P (2002) Biochemical analysis of the ceftazidime-hydrolising extended-spectrum β-lactamase CTX-M-15 and of its structurally related β-lactamase CTX-M-3. J Antimicrob Chemother 50:1031–1034

    Article  PubMed  CAS  Google Scholar 

  26. Stürenburg E, Mack D (2003) Extended-spectrum β-lactamases: implications for the clinical microbiological laboratory, therapy and infection control. J Infect 47:273–295

    Article  PubMed  Google Scholar 

  27. Schlesinger Y, Navon-Venezia S, Chmelnitsky I, Hammer-Münz O, Leavitt A, Gold HS, Schwaber MJ, Carmeli Y (2005) Characterization of extended-spectrum beta-lactamases (ESBLs) among Enterobacter isolates in Tel-Aviv. Antimicrob Agents Chemother 49:1150–1156

    Article  PubMed  CAS  Google Scholar 

  28. Nordmann P, Naas T (1994) Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class-A beta-lactamases. Antimicrob Agents Chemother 38:104–114

    PubMed  CAS  Google Scholar 

  29. Bauerfeind A, Stemplinger I, Jungwirth R, Ernst S, Casellas JM (1996) Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other β-lactamases. Antimicrob Agents Chemother 40:509–513

    Google Scholar 

  30. Steward CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson GJ, William PP, Brittain KL, Oliver A, McGowan JE, Tenover FC (2001) Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods. J Clin Microbiol 39:2864–2872

    Article  PubMed  CAS  Google Scholar 

  31. Chmelnitsky I, Carmeli Y, Leavitt A, Schwaber MJ, Navon-Venezia S (2005) CTX-M-2 and a new CTX-M-39 enzyme are the major extended-spectrum beta-lactamases in multiple Escherichia coli clones from Tel-Aviv. Antimicrob Agents Chemother 49:4745–4750

    Article  PubMed  CAS  Google Scholar 

  32. Sabate M, Tarrago R, Navarro F, Miro E, Verges C, Barbe J, Prats G (2000) Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-9) from Escherichia coli in Spain. Antimicrob Agents Chemother 44:1970–1973

    Article  PubMed  CAS  Google Scholar 

  33. Quellette M, Bissonnette L, Roy PH (1997) Precise insertion of antibiotic resistance determinants into Tn21-like transposons: nucleotide sequence of the OXA-1 β-lactamase gene. Proc Natl Acad Sci USA 84:7378–7387

    Google Scholar 

  34. Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, Ould-Hocine Z, Barnaud G, Delisle F, Rossier A, Lambert T, Phillipon A, Arlet G (2004) Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 48:1249–1255

    Article  PubMed  CAS  Google Scholar 

  35. Kim S, Kim J, Kang Y, Park Y, Lee B (2004) Occurrence of extended-spectrum beta-lactamases in members of the genus Shigella in the Republic of Korea. J Clin Microbiol 42:5264–5269

    Article  PubMed  CAS  Google Scholar 

  36. Acikgoz ZC, Gulay Z, Bicmen M, Gocer S, Gamberzade S (2003) CTX-M-3 extended-spectrum β-lactamase in a Shigella sonnei clinical isolate: first report from Turkey. Scand J Infect Dis 35:503–505

    Article  PubMed  CAS  Google Scholar 

  37. Pai H, Choi EC, Lee HJ, Hong JY, Jacoby GA (2001) Identification of CTX-M-14 extended-spectrum β-lactamase in clinical isolates of Shigella sonnei, Escherichia coli and Klebsiella pneumoniae in Korea. J Clin Microbiol 39:3747–3749

    Article  PubMed  CAS  Google Scholar 

  38. Radice M, Gonzales C, Power MC, Vidal P, Gutkind G (2001) Third-generation cephalosporin resistance in Shigella sonnei, Argentina. Emerg Infect Dis 7:442–443

    PubMed  CAS  Google Scholar 

  39. Navia MM, Capitano L, Ruiz J, Vargas M, Urassa H, Schellemberg D, Gascon J, Vila J (1999) Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania. J Clin Microbiol 37:3113–3117

    PubMed  CAS  Google Scholar 

  40. Siu LK, Lo JYC, Yuen PY, Chau MHNG, Ho PL (2000) β-Lactamases in Shigella flexneri isolated from Hong Kong and Shanghai and a novel OXA-1-like β-lactamase, OXA-30. Antimicrob Agents Chemother 44:2034–2038

    Article  PubMed  CAS  Google Scholar 

  41. Sirot D, Chanal C, Bennet R, Champs CD, Sirot J (2001) Inhibitor-resistant TEM-33 β-lactamase in a Shigella sonnei isolate. Antimicrob Agents Chemother 45:2179–2180

    Article  PubMed  CAS  Google Scholar 

  42. Peirano G, Agersø Y, Aarestrup FM, Rodrigues DP (2005) Occurrence of integrons and resistance genes among sulphonamide-resistant Shigella spp. from Brazil. J Antimicrob Chemother 55:301–305

    Article  PubMed  CAS  Google Scholar 

  43. Leverstein-van Hall MA, Fluit AC, Paauw A, Box ATA, Brisse S, Verhoef J (2002) Evaluation of the E test ESBL and BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. J Clin Microbiol 40:3703–3711

    Article  PubMed  CAS  Google Scholar 

  44. Lartigue M, Poirel L, Decousser J, Nordman P (2005) Multidrug-resistant Shigella sonnei and Salmonella enterica serotype typhimurium isolates producing CTX-M β-lactamases as causes of community-acquired infection in France. Clin Infect Dis 40:1069–1070

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors are grateful to C. Block, J.M. Shehadeh, E. Cohen, G. Rahav, and B. Reuveni for their assistance.

Author information

Authors and Affiliations

  1. Central Laboratories of the Ministry of Health, 9 Yaakov Eliav Street, P.O. Box 34410, Givat Shaul, Jerusalem, 91342, Israel

    V. Vasilev, R. Japheth, R. Yishai, N. Andorn & L. Valinsky

  2. Division of Epidemiology, Tel Aviv Sourasky Medical Center, 9 Weizmann Street, Tel Aviv, 64239, Israel

    S. Navon-Venezia, I. Chmelnitsky & Y. Carmeli

  3. Department of Epidemiology and Preventive Medicine, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv, 69978, Israel

    D. Cohen

Authors
  1. V. Vasilev
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Japheth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Yishai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Andorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Valinsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Navon-Venezia
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I. Chmelnitsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Y. Carmeli
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. D. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Vasilev.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vasilev, V., Japheth, R., Yishai, R. et al. Extended-spectrum β-lactamase-producing Shigella strains in Israel, 2000–2004. Eur J Clin Microbiol Infect Dis 26, 189–194 (2007). https://doi.org/10.1007/s10096-007-0263-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-007-0263-y

Keywords

Search

Navigation